Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 314, Issue 5, 2018, Pages H1033-H1042

  Dryer, Kathryn ^a   Gajjar, Mark ^b   Narang, Nikhil ^a   Lee, Margaret ^a   Paul, Jonathan ^a   Shah, Atman P ^a   Nathan, Sandeep ^a   Butler, Javed ^d   Davidson, Charles J ^c   Fearon, William F ^e   Shah, Sanjiv J ^c   Blair, John E A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Northwestern University ^*

^c NORTHWESTERN UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Heart failure with preserved ejection fraction; Microvascular

Indexed keywords

ADENOSINE; BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CORONARY MICROVASCULAR DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; INDEX OF MICROVASCULAR RESISTANCE; INVASIVE PROCEDURE; MALE; MICROANGIOPATHY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VASCULAR RESISTANCE; CASE CONTROL STUDY; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; ILLINOIS; MICROCIRCULATION; MICROVASCULATURE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY;

AGED; CASE-CONTROL STUDIES; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HEART FAILURE; HUMANS; ILLINOIS; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 85046903134     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00680.2017     Document Type: Article

References (47)

1. Adams V, Alves M, Fischer T, Rolim N, Werner S, Schütt N, Bowen TS, Linke A, Schuler G, Wisloff U. High-intensity interval training attenuates endothelial dysfunction in a Dahl salt-sensitive rat model of heart failure with preserved ejection fraction. J Appl Physiol 119: 745–752, 2015. doi:10.1152/japplphysiol.01123.2014.
2. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59: 998–1005, 2012. doi:10.1016/j.jacc.2011.11.040.
3. Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB Jr, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ, Tommaso CL; ACCF Task Force Members. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: a report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine. J Am Coll Cardiol 59: 2221–2305, 2012. doi:10.1016/j.jacc.2012.02.010.
4. Borbély A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C, Leite-Moreira AF, Bronzwaer JG, Papp Z, van der Velden J, Stienen GJ, Paulus WJ. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 104: 780–786, 2009. doi:10.1161/CIRCRESAHA.108.193326.
5. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL. Systolic and diastolic heart failure in the community. JAMA 296: 2209–2216, 2006. doi:10.1001/jama.296.18.2209.
6. Butler J, Hamo CE, Udelson JE, O’Connor C, Sabbah HN, Metra M, Shah SJ, Kitzman DW, Teerlink JR, Bernstein HS, Brooks G, Depre C, DeSouza MM, Dinh W, Donovan M, Frische-Danielson R, Frost RJ, Garza D, Gohring UM, Hellawell J, Hsia J, Ishihara S, Kay-Mugford P, Koglin J, Kozinn M, Larson CJ, Mayo M, Gan LM, Mugnier P, Mushonga S, Roessig L, Russo C, Salsali A, Satler C, Shi V, Ticho B, van der Laan M, Yancy C, Stockbridge N, Gheorghiade M. Reassessing phase II heart failure clinical trials: consensus recommendations. Circ Heart Fail 10: e003800, 2017. doi:10.1161/CIRCHEARTFAILURE.116.003800.
7. Dalos D, Mascherbauer J, Zotter-Tufaro C, Duca F, Kammerlander AA, Aschauer S, Bonderman D. Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction. J Am Coll Cardiol 68: 189–199, 2016. doi:10.1016/j.jacc.2016.04.052.
8. Edelmann F, Stahrenberg R, Gelbrich G, Durstewitz K, Angermann CE, Düngen HD, Scheffold T, Zugck C, Maisch B, Regitz-Zagrosek V, Hasenfuss G, Pieske BM, Wachter R. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol 100: 755–764, 2011. doi:10.1007/s00392-011-0305-4.
9. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Novel index for invasively assessing the coronary microcirculation. Circulation 107: 3129–3132, 2003. doi:10.1161/01.CIR.0000080700.98607.D1.
10. Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 51: 560–565, 2008. doi:10.1016/j.jacc.2007.08.062.
11. Gevaert AB, Shakeri H, Leloup AJ, Van Hove CE, De Meyer GR, Vrints CJ, Lemmens K, Van Craenenbroeck EM. Endothelial senescence contributes to heart failure with preserved ejection fraction in an aging mouse model. Circ Heart Fail 10: e003806, 2017. doi:10.1161/CIRCHEARTFAILURE.116.003806.
12. Gorcsan J 3rd, Tanaka H. Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 58: 1401–1413, 2011. doi:10.1016/j.jacc.2011.06.038.
13. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 4: 324–331, 2011. doi:10.1161/CIRCHEARTFAILURE.110.959890.
14. Hasdai D, Holmes DR Jr, Higano ST, Burnett JC Jr, Lerman A. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc 73: 1133–1140, 1998. doi:10.4065/73.12.1133.
15. Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL. Death in heart failure: a community perspective. Circ Heart Fail 1: 91–97, 2008. doi:10.1161/CIRCHEARTFAILURE.107.743146.
16. Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, Psaty BM, Bartz TM, Santhanakrishnan R, Lee DS, Chan C, Liu K, Blaha MJ, Hillege HL, van der Harst P, van Gilst WH, Kop WJ, Gansevoort RT, Vasan RS, Gardin JM, Levy D, Gottdiener JS, de Boer RA, Larson MG. Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes. Circ Heart Fail 9: e003116, 2016. doi:10.1161/CIRCHEARTFAILURE.115.003116.
17. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH, Le Jemtel TH. Vascular inflammation in obesity and sleep apnea. Circulation 121: 1014–1021, 2010. doi:10.1161/CIRCULATIONAHA.109.900357.
18. Jeremias A, Maehara A, Généreux P, Asrress KN, Berry C, De Bruyne B, Davies JE, Escaned J, Fearon WF, Gould KL, Johnson NP, Kirtane AJ, Koo BK, Marques KM, Nijjer S, Oldroyd KG, Petraco R, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JA, van ’t Veer M, Mintz GS, Stone GW. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol 63: 1253–1261, 2014. doi:10.1016/j.jacc.2013.09.060.
19. Kato S, Saito N, Kirigaya H, Gyotoku D, Iinuma N, Kusakawa Y, Iguchi K, Nakachi T, Fukui K, Futaki M, Iwasawa T, Kimura K, Umemura S. Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction. J Am Heart Assoc 5: e002649, 2016. doi:10.1161/JAHA.115.002649.
20. Kern MJ. Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation 101: 1344–1351, 2000. doi:10.1161/01.CIR.101.11.1344.
21. Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, Kalman J, Phillips RA, Steingart R, Brown EJ Jr, Berkowitz R, Moskowitz R, Soni A, Mancini D, Bijou R, Sehhat K, Varshneya N, Kukin M, Katz SD, Sleeper LA, Le Jemtel TH; New York Heart Failure Consortium. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 43: 1432–1438, 2004. doi:10.1016/j.jacc.2003.11.040.
22. Krüger M, Kötter S, Grützner A, Lang P, Andresen C, Redfield MM, Butt E, dos Remedios CG, Linke WA. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 104: 87–94, 2009. doi:10.1161/CIRCRESAHA.108.184408.
23. Lam CSP, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 53: 1119–1126, 2009. doi:10.1016/j.jacc.2008.11.051.
24. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28: 1–39.e14, 2015. doi:10.1016/j.echo.2014.10.003.
25. Lee JM, Jung JH, Hwang D, Park J, Fan Y, Na SH, Doh JH, Nam CW, Shin ES, Koo BK. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J Am Coll Cardiol 67: 1158–1169, 2016. doi:10.1016/j.jacc.2015.12.053.
26. Martos R, Baugh J, Ledwidge M, O’Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115: 888–895, 2007. doi:10.1161/CIRCULATIONAHA.106.638569.
27. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 285: 1441–1446, 1971. doi:10.1056/NEJM197112232852601.
28. Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5: 710–719, 2012. doi:10.1161/CIRCHEARTFAILURE.112.968594.
29. Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 131: 550–559, 2015. doi:10.1161/CIRCULATIONAHA.114.009625.
30. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29: 277–314, 2016. doi:10.1016/j.echo.2016.01.011.
31. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation 113: 2054–2061, 2006. doi:10.1161/CIRCULATIONAHA.105.603522.
32. Oktay AA, Shah SJ. Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessons. Curr Cardiol Rev 11: 42–52, 2015. doi:10.2174/1573403X09666131117131217.
33. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251–259, 2006. doi:10.1056/NEJMoa052256.
34. Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 47: 320–332, 2005. doi:10.1016/j.pcad.2005.02.010.
35. Pandey A, LaMonte M, Klein L, Ayers C, Psaty BM, Eaton CB, Allen NB, de Lemos JA, Carnethon M, Greenland P, Berry JD. Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol 69: 1129–1142, 2017. doi:10.1016/j.jacc.2016.11.081.
36. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62: 263–271, 2013. doi:10.1016/j.jacc.2013.02.092.
37. Picard MH, Adams D, Bierig SM, Dent JM, Douglas PS, Gillam LD, Keller AM, Malenka DJ, Masoudi FA, McCulloch M, Pellikka PA, Peters PJ, Stainback RF, Strachan GM, Zoghbi WA; American Society of Echocardiography. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr 24: 1–10, 2011. doi:10.1016/j.echo.2010.11.006.
38. Pijls NH, De Bruyne B, Smith L, Aarnoudse W, Barbato E, Bartunek J, Bech GJ, Van De Vosse F. Coronary thermodilution to assess flow reserve: validation in humans. Circulation 105: 2482–2486, 2002. doi:10.1161/01.CIR.0000017199.09457.3D.
39. Rommel KP, von Roeder M, Latuscynski K, Oberueck C, Blazek S, Fengler K, Besler C, Sandri M, Lücke C, Gutberlet M, Linke A, Schuler G, Lurz P. Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 67: 1815–1825, 2016. doi:10.1016/j.jacc.2016.02.018.
40. Santos AB, Kraigher-Krainer E, Gupta DK, Claggett B, Zile MR, Pieske B, Voors AA, Lefkowitz M, Bransford T, Shi V, Packer M, McMurray JJ, Shah AM, Solomon SD; PARAMOUNT Investigators. Impaired left atrial function in heart failure with preserved ejection fraction. Eur J Heart Fail 16: 1096–1103, 2014. doi:10.1002/ejhf.147.
41. Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol 59: 442–451, 2012. doi:10.1016/j.jacc.2011.09.062.
42. Shah AM, Shah SJ, Anand IS, Sweitzer NK, O’Meara E, Heitner JF, Sopko G, Li G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD; TOPCAT Investigators. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Circ Heart Fail 7: 104–115, 2014. doi:10.1161/CIRCHEARTFAILURE.113.000887.
43. Taube A, Schlich R, Sell H, Eckardt K, Eckel J. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 302: H2148–H2165, 2012. doi:10.1152/ajpheart.00907.2011.
44. van Heerebeek L, Hamdani N, Falcão-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 126: 830–839, 2012. doi:10.1161/CIRCULATIONAHA.111.076075.
45. van ’t Veer M, Adjedj J, Wijnbergen I, Tóth GG, Rutten MC, Barbato E, van Nunen LX, Pijls NH, De Bruyne B. Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation. EuroIntervention 12: 701–707, 2016. doi:10.4244/EIJV12I6A114.
46. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tschöpe C. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4: 44–52, 2011. doi:10.1161/CIRCHEARTFAILURE.109.931451.
47. Williams RP, de Waard GA, De Silva K, Lumley M, Asrress K, Arri S, Ellis H, Mir A, Clapp B, Chiribiri A, Plein S, Teunissen PF, Hollander MR, Marber M, Redwood S, van Royen N, Perera D. Doppler versus thermodilution-derived coronary microvascular resistance to predict coronary microvascular dysfunction in patients with acute myocardial infarction or stable angina pectoris. Am J Cardiol 121: 1–8, 2018. doi:10.1016/j.amjcard.2017.09.012.